← Leaderboards
Ralph C Dornburg
Thomas Jefferson University
$1,301,573
Attributed
$1,301,573
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,301,573 · 2
By mechanism
R01$1,301,573 · 2
Top collaborators
No co-investigators on record.
Most similar at Thomas Jefferson University
Same institution · by research overlap
- Harris Goldstein$29,313,609
- Laurence Crane Eisenlohr$22,538,505
- Timothy L Manser$10,016,107
- David S Strayer$8,559,654
- Yuri Sykulev$9,058,653
Others in their field
Top investigators on “Gene Therapy”
- David Heimbrook · Leidos Biomedical Research, Inc.$164,199,916
- Gregory H Reaman · National Childhood Cancer Foundation$155,841,493
- Randall J Bateman · Washington University$122,781,098
- Eric Martin McDade · Washington University$94,632,845
- Ronald G Crystal · Weill Medical College Of Cornell Univ$82,649,124
- Robert B. Diasio · University Of Alabama At Birmingham$73,470,685
Research focus
Gene TherapyTransfection /Expression VectorScid MouseHiv InfectionsAids TherapyHuman Immunodeficiency Virus 1Polymerase Chain ReactionAidsCell TypeElectroporationFluorescence MicroscopyGene ExpressionGenetic ManipulationGenetic TranscriptionNonhuman Therapy EvaluationVirus ReplicationHuman TissueRetroviridaeAntiaids AgentMethod DevelopmentGenetic TransductionMolecular CloningNeuronsVirus Genetics
Grant awards (5)
TARGETED VECTORS TO BLOCK HIV1 REPLICATION$308,840
R01 · FY2002 · AI
TARGETED VECTORS TO BLOCK HIV1 REPLICATION$300,259
R01 · FY2001 · AI
Retroviral Vectors for Gene Therapy of HIV-1 Infection$274,750
R01 · FY2001 · AI
TARGETED VECTORS TO BLOCK HIV1 REPLICATION$243,219
R01 · FY2000 · AI
RETROVIRAL VECTORS FOR GENE THERAPY OF HIV1 INFECTION$174,505
R01 · FY2000 · AI